NCT02115282 2025-12-18Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticNational Cancer Institute (NCI)Phase 3 Active not recruiting608 enrolled 18 charts